16 Oct
2020
08:15 E.S.T.

Calyxt Announces $15 Million Registered Direct Offering

Read more

02 Sep
2020
16:30 E.S.T.

Cellectis to Participate in Upcoming Investor Conferences

Read more

05 Aug
2020
16:30 E.S.T.

Cellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2020

Read more

29 Jul
2020
16:30 E.S.T.

Cellectis to Hold Second Quarter 2020 Earnings Call on Thursday, August 6, 2020 at 7:30AM EDT

Read more

21 Jul
2020
16:30 E.S.T.

Cellectis Appoints Biopharma Veteran Steve Doares, Ph.D.,  as Senior Vice President of US Manufacturing

Read more

06 Jul
2020
17:20 E.S.T.

To Fully Focus on Cellectis, Dr. André Choulika Retires From Calyxt’s Board of Directors

Read more

06 Jul
2020
16:50 E.S.T.

Cellectis Reports Clinical Hold Placed on MELANI-01 Study

Read more

29 Jun
2020
16:30 E.S.T.

Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 29, 2020

Read more

25 Jun
2020
16:30 E.S.T.

Cellectis Published Streamlined Manufacturing Method to Generate Ultrapure Allogeneic CAR T-Cell Therapies

Read more

18 May
2020
16:30 E.S.T.

Cellectis Appoints Biopharma Veteran Leopold Bertea as Senior Vice President of Technical Operations - Europe

Read more